Shanghai Pharmaceuticals SHPMY Stock
Shanghai Pharmaceuticals Price Chart
Shanghai Pharmaceuticals SHPMY Financial and Trading Overview
| Shanghai Pharmaceuticals stock price | 7.08 USD |
| Previous Close | 7.08 USD |
| Open | 6.45 USD |
| Bid | 6.35 USD x 40000 |
| Ask | 7.32 USD x 40000 |
| Day's Range | 6.45 - 6.45 USD |
| 52 Week Range | 6.41 - 8.3 USD |
| Volume | 1 USD |
| Avg. Volume | 66 USD |
| Market Cap | 5.25B USD |
| Beta (5Y Monthly) | 0.151 |
| PE Ratio (TTM) | 7.693478 |
| EPS (TTM) | 0.92 USD |
| Forward Dividend & Yield | 0.33 (4.68%) |
| Ex-Dividend Date | September 17, 2026 |
| 1y Target Est | N/A |
SHPMY Valuation Measures
| Enterprise Value | 32.6B USD |
| Trailing P/E | 7.693478 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 5.15 |
| Price/Sales (ttm) | 0.018135907 |
| Price/Book (mrq) | 0.4492381 |
| Enterprise Value/Revenue | 0.113 |
| Enterprise Value/EBITDA | 2.977 |
Trading Information
Shanghai Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.151 |
| 52-Week Change | -14.72% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 8.3 USD |
| 52 Week Low | 6.41 USD |
| 50-Day Moving Average | 7.23 USD |
| 200-Day Moving Average | 7.55 USD |
SHPMY Share Statistics
| Avg. Volume (3 month) | 66 USD |
| Avg. Daily Volume (10-Days) | 50 USD |
| Shares Outstanding | 183.81M |
| Float | 309.74M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.45 |
| Trailing Annual Dividend Yield | 6.35% |
| 5 Year Average Dividend Yield | 413.00% |
| Payout Ratio | 0.3198 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 1.64% |
| Operating Margin (ttm) | 3.55% |
| Gross Margin | 10.92% |
| EBITDA Margin | 3.78% |
Management Effectiveness
| Return on Assets (ttm) | 2.34% |
| Return on Equity (ttm) | 6.95% |
Income Statement
| Revenue (ttm) | 289.46B USD |
| Revenue Per Share (ttm) | 390.28 USD |
| Quarterly Revenue Growth (yoy) | 1.89% |
| Gross Profit (ttm) | 31.62B USD |
| EBITDA | 10.95B USD |
| Net Income Avi to Common (ttm) | 4.77B USD |
| Diluted EPS (ttm) | 0.92 |
| Quarterly Earnings Growth (yoy) | -33.20% |
Balance Sheet
| Total Cash (mrq) | 45.99B USD |
| Total Cash Per Share (mrq) | 62.01 USD |
| Total Debt (mrq) | 58.91B USD |
| Total Debt/Equity (mrq) | 63.49 USD |
| Current Ratio (mrq) | 1.342 |
| Book Value Per Share (mrq) | 15.755566 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 9.61B USD |
| Levered Free Cash Flow (ttm) | 1.27B USD |
Profile of Shanghai Pharmaceuticals
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Shanghai Pharmaceutical Building |
| ZIP | 200020 |
| Phone | 86 21 6373 0908 |
| Website | https://www.sphchina.com |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 48640 |
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Q&A For Shanghai Pharmaceuticals Stock
What is a current SHPMY stock price?
Shanghai Pharmaceuticals SHPMY stock price today per share is 7.08 USD.
How to purchase Shanghai Pharmaceuticals stock?
You can buy SHPMY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Pharmaceuticals?
The stock symbol or ticker of Shanghai Pharmaceuticals is SHPMY.
Which industry does the Shanghai Pharmaceuticals company belong to?
The Shanghai Pharmaceuticals industry is Medical Distribution.
How many shares does Shanghai Pharmaceuticals have in circulation?
The max supply of Shanghai Pharmaceuticals shares is 741.67M.
What is Shanghai Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Shanghai Pharmaceuticals PE Ratio is 7.69347800 now.
What was Shanghai Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Shanghai Pharmaceuticals EPS is 0.92 USD over the trailing 12 months.
Which sector does the Shanghai Pharmaceuticals company belong to?
The Shanghai Pharmaceuticals sector is Healthcare.
